Orchestra BioMed Hldgs Q3 EPS $(0.30) Beats $(0.40) Estimate, Sales $91.000K Miss $106.000K Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings BeatsEarnings Misses
Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.40) by 25 percent. This is a 25 percent increase over losses of $(0.40) per share from
Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.40) by 25 percent. This is a 25 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $91.000 thousand which missed the analyst consensus estimate of $106.000 thousand by 14.15 percent. This is a 89.43 percent decrease over sales of $861.000 thousand the same period last year.